Skip to main content
SpringerLink
Log in

Cutaneous T-Cell Lymphomas and Rare T-Cell Non-Hodgkin Lymphomas

  • Chapter
Pediatric Lymphomas

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 968 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Agnarsson B, Kadin ME. Ki-1-positive large-cell lymphoma: A morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988; 12:264–274.

    PubMed  CAS  Google Scholar 

  • Agnarsson BA, Vonderheid EC, Kadin ME. Cutaneous T-cell lymphoma with suppressor/cytotoxic (CD8) phenotype: Identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol. 1990;22:569–577.

    PubMed  CAS  Google Scholar 

  • Assaf C, Mummel M, Steinhoff M, Geilen CC, Orawa H, Stain H, Orfanos CE. Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications. Blood 2005;105:503–510.

    Article  PubMed  CAS  Google Scholar 

  • Bekkenk M, Geelen FAMJ, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30-positive lymphoproliferative disorders: long term follow-up data of 219 patients and guidelines for diagnosis and treatment. A report from the Dutch Cutaneous Lymphoma Group. Blood 2000;95:3653–3661.

    PubMed  CAS  Google Scholar 

  • Belhadj K, Reyes F et al. Hepatosplenic gamma-delta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: a report on a series of 21 patients. Blood 2003;102: 4261–4269.

    Article  PubMed  CAS  Google Scholar 

  • Beljaards RC, Meijer CJLM, Ber-H2, Scheffer E, et al. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 1989;135:1169–1178.

    PubMed  CAS  Google Scholar 

  • Berti E, Tomasini D, Vermeer MH, Meijer CJLM, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T-cell lymphoma: a distinct clinicopathologic entity with an aggressive clinical behaviour. Am J Pathol 1999;155: 483–492.

    PubMed  CAS  Google Scholar 

  • Bonzheim I, Geissinger E, Roth S, Zettla A, Marx S, Rosenwald A, Mueller-Hermelink HK, Ruediger T. Anaplastic large cell lymphomas lack expresion of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 2004; 104:3358–3360.

    Article  PubMed  CAS  Google Scholar 

  • Bunn PA, Lamberg SI. Report of the Committee on Staging and Classification of Cutaenous T-cell lymphomas. Cancer Treatment Reports 1979; 63:725–728.

    PubMed  Google Scholar 

  • Burg G, Kempf W, Kazakov DV, et al. Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich lymphoma. Clinicopathologic study of four cases and review of the literature. Br J Dermatol 2003; 148:1–7.

    Article  Google Scholar 

  • Burg G, Dummer R, Wilhelm M, et al. A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med 1991;325:1078–1081.

    Article  PubMed  CAS  Google Scholar 

  • Cabanillas F, Armitage J, Pugh WC, Weisenburger D, Duvic M. Lymphomatoid papulosis: a T-cell dyscrasia with propensity to transform to malignant lymphoma. Ann Intern Med 1995;122:210–217.

    PubMed  CAS  Google Scholar 

  • Chott A, Vonderheid EC, Miao NN, Balk SP, Kadin ME. Detection of the same dominant T cell clone in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol 1996;106:696–700.

    Article  PubMed  CAS  Google Scholar 

  • Cooke CB, Krenacs M, Stetler-Stevenson M, et al. Hepatosplenic gamma/delta T-cell lymphoma: a distinict clinical pathologic entity of gamma/delta T-cell origin. Blood 1996;88:4265–4274.

    PubMed  CAS  Google Scholar 

  • Davis TM, Morton CC, Miller-Cassman R, Balk SP, Kadin ME. Hodgkin’s disease, lymphomatoid papulosis and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 1992;326:1115–1122.

    Article  PubMed  CAS  Google Scholar 

  • De Bruin PC, Beljaards RC, van Heerde P, et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-or null cell phenotype. Histopathol 1993;23:127–135.

    Google Scholar 

  • De Couteau JF, Butmarc JR, Kinney MC, Kadin ME. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large cell lymphoma of nodal origin. Blood 1996;87:3437–3441.

    Google Scholar 

  • Dereure O, Levi E, Vonderheid EC, Kadin ME. Infrequent mutations of Fas but not p53 or Bax in early mycosis fungoides. A possible mechanism for accumulation of malignant T-lymphocytes in the skin. J Invest Derm 2002; 118:949–956.

    Article  PubMed  CAS  Google Scholar 

  • Diamandidou E, Cohen PR, Kurzrock R. Mycosis fungoides and Sezary syndrome. Blood 1996; 88:2385–2409.

    PubMed  CAS  Google Scholar 

  • Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R. Transformation of mycosis fungoides/Sézary syndrome: clinical characteristics and prognosis. Blood. 1998;92:1150–1159.

    PubMed  CAS  Google Scholar 

  • Domm J, Thompson M, et al. Allogeneic bone marrow transplantation for chemotherapy-refractory gammadelta hepatosplenic T-cell lymphoma. J Pediatr Hematol Oncol 2005; 27(11): 607–610.

    Article  PubMed  Google Scholar 

  • Dummer R, Kempf W, Hess Schmid M, et al. Therapy of cutaneous lymphoma — current practice and future developments. Onkologie 2003; 26:366–372.

    Article  PubMed  CAS  Google Scholar 

  • Duvic M, Cather JC. Emerging new therapies for cutaneous T-cell lymphoma. Dermatol Clin 2000;18:147–156.

    PubMed  CAS  Google Scholar 

  • Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Eng J Med 1987; 316:297–303.

    Article  CAS  Google Scholar 

  • El Shabrawi-Caelen L, Kerl H, Cerroni L. Lymphomatoid papulosis. Reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 2004;140:441–447.

    Article  PubMed  Google Scholar 

  • Farcet J, Galulard P. Marolleau J, et al. Hepatosplenic T-cell lymphoma: Sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor γδ. Blood 1990;75:2213–2219.

    PubMed  CAS  Google Scholar 

  • Fink-Puches R, Chott A, et al. The spectrum of cutaneous lymphomas in patients less than 20 years of age. Pediatr Dermatol 2004; 21(5): 525–33.

    Article  PubMed  Google Scholar 

  • Flaig MJ, Cerroni L, Schuhmann K, et al. Follicular mycosis fungoides. A histopathologic analysis of nine cases. J Cutan Pathol 2001; 28:525–30.

    Article  PubMed  CAS  Google Scholar 

  • Gaulard P, Zafrani ES, Mavier P, et al. Peripheral T-cell lymphoma presenting as predominant liver disease: report of 3 cases. Hepatology 1986; 6:864–868.

    PubMed  CAS  Google Scholar 

  • Gaulard P, Bourquelot P, Kanavaros P, et al. Expression of alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas: identification of a subset of gamma/delta T-cell lymphomas. Am J Pathol 1990;137:617–628.

    PubMed  CAS  Google Scholar 

  • Gellrich S, Wernicke M, Wilks A, et al. The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T-cells (CD30-negative). J Invest Dermatol 2004; 122:859–61.

    Article  PubMed  CAS  Google Scholar 

  • Gniadecki R, Lukowsky A, Rossen K, Madsen HO, Thomsen K, Wulf HC. Bone marrow precursor of extranodal T-cell lymphoma. Blood 2003; 102:3797–99.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez CL, Medeiros LJ, Braziiel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991; 15:17–27.

    PubMed  CAS  Google Scholar 

  • Groves FD, Linet MS, Travis LB, Devesa SS. Cancer Surveillance Series: Non-Hodgkin’s Lymphoma Incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92:1240–1251

    Article  PubMed  CAS  Google Scholar 

  • Hoefnagel J, Dijkman R, et al. Distinct types of primary cutaneous large B cell lymphoma identified by gene expression profiling. Blood 2005; 105: 3671–3678

    Article  PubMed  CAS  Google Scholar 

  • Hoque SR, Child FJ, Whittaker SJ, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol 2003; 148:516–525.

    Article  PubMed  CAS  Google Scholar 

  • Jones GW, Kacinski BM, Wilson LD, et al. Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol 2002; 47:364–370.

    Article  PubMed  Google Scholar 

  • Kadin ME, Kamoun M, Lamberg J. Erythrophagocytic T gamma lymphoma. A clinicopathologic entity resembling malignant histiocytosis. N Engl J Med 1981; 304:648–653.

    Article  PubMed  CAS  Google Scholar 

  • Kadin M, Nasu K, Sako D, Said J, Vonderheid E. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin’s Disease associated antigens. Am J Pathol 1985; 119:315–25

    PubMed  CAS  Google Scholar 

  • Kahwash S, Qualman S. Cutaneous lymphoblastic lymphoma in children: a report of six cases with precursor B cell lineage. Pediatr Dev Pathol 2002; 5(1): 45–53.

    Article  PubMed  Google Scholar 

  • Karenko L, Kahkonen M, Hyytinen ER, Lindlof M, Ranki A. Notable losses at specific regions of chromosomes 10q and 13q in the Sezary syndrome detected by comparative genomic hybridization. J Invest Dermatol 1999; 112:392–395.

    Article  PubMed  CAS  Google Scholar 

  • Kaudewitz P, Stein H, Dallenbach F, et al. Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical characteristics. Am J Pathol 1989; 135:359–367.

    PubMed  CAS  Google Scholar 

  • Kaye FJ, Bunn PA, Steinberg SM, et al. A randomized trial comparing combination electron beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Eng J Med 1989; 321:784–790.

    Article  Google Scholar 

  • Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 2003;139:857–866.

    Article  PubMed  Google Scholar 

  • Kummer JA, Vermeer MH, Dukers DF, Meijer CJLM, Willemze R. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol 1997; 109:636–40.

    Article  PubMed  CAS  Google Scholar 

  • Kupper T, Fuhlbrigge R. Immune surveillance in the skin: mechanisms and clinical consequences. Nature Reviews, Immunology 2004; 4(3): 211–22

    Article  CAS  Google Scholar 

  • Lin P, Jones D, et al. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol 2002;24: 1480–90.

    Google Scholar 

  • Liu HL, Hoppe RT, Kohler S, Harvell JD, Reddy S, Kim YH. CD30+ cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol 2003; 49:1049–1058.

    Article  PubMed  Google Scholar 

  • Lorincz AL. Cutaneous T-cell lymphoma (mycosis fungoides). Lancet 1996; 347:871–876.

    Article  PubMed  CAS  Google Scholar 

  • Lundin J, Hagberg H, Repp R, et al. Phase II study of alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) in patients with advanced mycosis fungoides. Blood 2003;101:4267–4272.

    Article  PubMed  CAS  Google Scholar 

  • Macon WR, Levy NB, Kurtin PJ, et al. Hepatosplenic alphabeta T-cell lymphomas: report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol 2001; 25:285–296.

    Article  PubMed  CAS  Google Scholar 

  • Mao X, Lillington D, Scarisbrick JJ, et al. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br J Dermatol 2002; 147:464–475.

    Article  PubMed  CAS  Google Scholar 

  • Mao X, Lillington DM, Czepulkowski B, Russell-Jones R, Young BD, Whittaker S. Molecular cytogenetic characterization of Sezary syndrome. Genes Chromosomes Cancer 2003a; 36:250–260.

    Article  PubMed  CAS  Google Scholar 

  • Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker SJ. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 2003b; 15(101):1513–1519.

    Article  CAS  Google Scholar 

  • Marzano AV, Berti E, Paulli M, et al. Cytophagic histiocytic panniculitis and subcutaneous panniculities-like T-cell lymphoma: report of 7 cases. Arch Dermatol 2000; 136:889–896.

    Article  PubMed  CAS  Google Scholar 

  • Mori M, Mannuelli C, Pimpinelli N, et al. CD30-CD30L interaction in primary cutaneous CD30+ T-cell lymphomas: A clue to the pathophysiology of clinical regression. Blood 1999; 94: 3077–83.

    PubMed  CAS  Google Scholar 

  • Murphy S, Fairclough D. Non-Hodgkin’s lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol 1989; 7(2): 186–93.

    PubMed  CAS  Google Scholar 

  • Nickoloff BJ. Light-microscopic assessment of 100 patients with patch/plaque-stage mycosis fungoides. Am J Dermatopathol 1988; 10:469–77.

    Article  PubMed  CAS  Google Scholar 

  • Nijsten T, Curiel-Lewandrowski C, Kadin ME. Lymphomatoid papulosis in children. A retrospective cohort study of 35 cases. Arch Dermatol 2004;140:306–312.

    Article  PubMed  Google Scholar 

  • Olsen EA, Bunn PA. Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995;9:1089–1097.

    PubMed  CAS  Google Scholar 

  • Paulli M, Berti E, Rosso R, et al. CD30/Ki-1 positive lymphoproliferative disorders of the skin: clinicopathologic correlation and and statistical analysis of 86 cases. J Clin Oncol 1995; 13:1343–1354.

    PubMed  CAS  Google Scholar 

  • Peters K, Knoll JHM, Kadin ME. Cytogenetic findings in regressing skin lesions of lymphomatoid papulosis. Cancer Genetics Cytogenetics 1995; 80:13–16.

    Article  CAS  Google Scholar 

  • Ruebben A, Kempf W, Kadin ME, Zimmermann DR, Burg G. Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma revealed by microdissection and allelotyping. Exp Dermatol 2004;13:472.

    Article  CAS  Google Scholar 

  • Russell-Jones R. Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies. Br J Dermatol 2000; 142:16–21

    Article  PubMed  CAS  Google Scholar 

  • Salhany KE, Macon WR, Choi JK, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 1998;22:881–893.

    Article  PubMed  CAS  Google Scholar 

  • Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003;97:610–627.

    Article  PubMed  Google Scholar 

  • Sausville EA, Eddy JL, Makuch RW, et al. Histopathological staging at initial diagnosis of mycosis fungoidies and Sezary syndrome: Definition of three distinctive prognostic groups. Ann Intern Med 1988, 109:372–382.

    PubMed  CAS  Google Scholar 

  • Scheffer E, Meijer CJLM, van Vloten WA, Willemze R. A histologic study of lymph nodes from patients with the Sezary syndrome. Cancer 1986;57:2375–2380.

    Article  PubMed  CAS  Google Scholar 

  • Sentis HJ, Willemze, Scheffer E. Histopathologic studies in Sezary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. J Am Acad Dermatol 1986;15:1217–1226.

    PubMed  CAS  Google Scholar 

  • Sibaud V, Beylot-Barry M, Thiebaut R, et al. Bone marrow histopathologic and molecular staging in epidermotropic T-cell lymphomas. Am J Clin Pathol 2003;119:414–423.

    Article  PubMed  Google Scholar 

  • Smoller BR, Santucci M, Wood GS, Whittaker SJ. Histopathology and genetics of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 2003;17:1277–1311.

    Article  PubMed  Google Scholar 

  • Thangavelu M, Finn WG, Yelavarthi KK, et al. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sezary syndrome. Blood 1997;89:3371–3377.

    PubMed  CAS  Google Scholar 

  • Toonstra J, Henquet CJM, van Weelden H, van der Putte SCJ, van Vloten WA. Actinic reticuloid: a clinical, photobiologic, histopathologic and follow-up study of 16 cases. J Am Acad Dermatol 1989;21:205–214

    PubMed  CAS  Google Scholar 

  • Trotter MJ, Whittaker SJ, Orchard GE, Smith NP. Cutaneous histopathology of Sezary syndrome: a study of 41 cases with a proven circulating T-cell clone. J Cutan Pathol 1997;24:286–291.

    Article  PubMed  CAS  Google Scholar 

  • Van Doorn R, Scheffer E, Willemze R. Follicular mycosis fungoides: a distinct disease entity with or without associated follicular mucinosis. Arch Dermatol 2001;138:191–198.

    Article  Google Scholar 

  • Van Doorn R, Van Haselen CW, van Voorst VPC et al. Mycosis fungoides: disease evolution and prognosis in 309 Dutch patients. Arch Dermatol 2000:136:504–510.

    Article  PubMed  Google Scholar 

  • Varga FJ, Vonderheid EC, Olbricht SM, Kadin ME. Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et variolaformis acuta (PLEVA). Am Pathol 1990;136: 979–987.

    CAS  Google Scholar 

  • Vermeer MH, Geelen FAMJ, Kummer JA, et al. Expression of cytotoxic proteins by neoplastic T-cells in mycosis fungoides is associated with progression from plaque stage to tumor stage disease. Am J Pathol 1999;154:1203–1210

    PubMed  CAS  Google Scholar 

  • Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol 1996;34:470–480.

    Article  PubMed  CAS  Google Scholar 

  • Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002;46:95–106.

    Article  PubMed  Google Scholar 

  • Wain EM, Orchard GE, Whittaker SJ, Spittle M, Russell-Jones R. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study. Cancer 2003;98:2282–2290.

    Article  PubMed  Google Scholar 

  • Wang CC, Tien JF, Lin MR, et al. Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma: a new cytogenetic-clinicopathologic entity. Genes Chromosomes Cancer 1995;12:161–164.

    PubMed  CAS  Google Scholar 

  • Wang HH, Lach L, Kadin ME. Epidemiology of lymphomatoid papulosis. Cancer 1992; 70:2951–7.

    Article  PubMed  CAS  Google Scholar 

  • Wang HH, Myers T, Lach LJ, Hsieh CC, Kadin ME. Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis. Cancer 1999; 86:1240–5.

    Article  PubMed  CAS  Google Scholar 

  • Weenig RH, Ng CS, Perniciaro C. Subcutaneous panniculitis-like T-cell lymphoma. Am J Dermatopathol 2001;23:206–215.

    Article  PubMed  CAS  Google Scholar 

  • Weiss L, Wood G, Trela M, Warnke RA, Sklar J. Clonal T-cell populations in lymphomatoid papulosis. N Engl J Med 1986;315:475–479.

    Article  PubMed  CAS  Google Scholar 

  • Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003;149:1095–1107.

    Article  PubMed  CAS  Google Scholar 

  • Whittam LR, Calonje E, Orchard G, Fraser-Andrews EA, Woolford A, Russell-Jones R. CD8-positive juvenile onset mycosis fungoides: an immunohistochemical and genotypic analysis of six cases. Br J Dermatol 2000;143:1199–1204.

    Article  PubMed  CAS  Google Scholar 

  • Wieselthier JS, Koh HK. Sézary syndrome: diagnosis, prognosis and critical review of treatment options. J Am Acad Dermatol 1990;22:381–401

    Article  PubMed  CAS  Google Scholar 

  • Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30+ lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993; 28:973–980

    PubMed  CAS  Google Scholar 

  • Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas. A Proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (EORTC). Blood 1997; 90:354–371.

    PubMed  CAS  Google Scholar 

  • Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification of cutaneous lymphoma. Blood 2005;105(10): 3768–85.

    Article  PubMed  CAS  Google Scholar 

  • Willers J, Dummer R, Kempf W, Kundig T, Burg G, Kadin ME. Proliferation of CD30+ T helper 2 cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. Clin Cancer Res 2003; 9:2744–54.

    PubMed  CAS  Google Scholar 

  • Yawalkar N, Ferenczi K, Jones DA, Yamanaka K, Suh K-Y, Sadat S, Kupper TS. Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma. Blood 2003; 102:4059–4066.

    Article  PubMed  CAS  Google Scholar 

  • Zackheim HS, Amin S, Kadhani-Sabet M, McMillan A. Prognosis in cutaneous T-cell lymphoma by skin stage: long term survival in 489 patients. J Am Acad Dermatol 1999;40:418–25.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Yamins 309 330 Brookline Ave., Boston, MA, 02215, USA

    M. E. Kadin M.D.

Authors
  1. M. E. Kadin M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA

    Howard J. Weinstein

  2. Department of Pediatrics, University of Tennessee Health Science Center College of Medicine, 332 North Lauderdale, Memphis, TN, 28105, USA

    Melissa M. Hudson

  3. Department of Hematology-Oncology, St. Jude Children’s Research Hospital, 332 North Lauderdale, Memphis, TN, 28105, USA

    Melissa M. Hudson

  4. School of Medicine, Department of Hematology-Oncology, Stanford University, 300 Pasteur Drive, Stanford, CA, 94305-5208, USA

    Michael P. Link

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kadin, M.E. (2007). Cutaneous T-Cell Lymphomas and Rare T-Cell Non-Hodgkin Lymphomas. In: Weinstein, H.J., Hudson, M.M., Link, M.P. (eds) Pediatric Lymphomas. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68753-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68753-5_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20356-8

  • Online ISBN: 978-3-540-68753-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation